Neurocognitive insight and objective cognitive functioning in schizophrenia

Cynthia Z. Burton, Philip D Harvey, Thomas L. Patterson, Elizabeth W. Twamley

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Neurocognitive impairment is a core component of schizophrenia affecting everyday functioning; the extent to which individuals with schizophrenia show awareness of neurocognitive impairment (neurocognitive insight) is unclear. This study investigated neurocognitive insight and examined the cross-sectional relationships between neurocognitive insight and objective neurocognition and functional capacity performance in a large outpatient sample.214 participants with schizophrenia-spectrum disorders completed measures of neurocognition, functional capacity, and self-reported neurocognitive problems. Latent profile analysis classified participants with regard to neuropsychological performance and self-report of neurocognitive problems. The resulting classes were then compared on executive functioning performance, functional capacity performance, and psychiatric symptom severity.More than three quarters of the sample demonstrated objective neurocognitive impairment (global deficit score ≥ 0.50). Among the participants with neurocognitive impairment, 54% were classified as having "impaired" neurocognitive insight (i.e., reporting few neurocognitive problems despite having objective neurocognitive impairment). Participants with impaired vs. intact neurocognitive insight did not differ on executive functioning measures or measures of functional capacity or negative symptom severity, but those with intact neurocognitive insight reported higher levels of positive and depressive symptoms.A substantial portion of individuals with schizophrenia and objectively measured neurocognitive dysfunction appear unaware of their deficits. Patient self-report of neurocognitive problems, therefore, is not likely to reliably assess neurocognition. Difficulty self-identifying neurocognitive impairment appears to be unrelated to executive functioning, negative symptoms, and functional capacity. For those with intact neurocognitive insight, improving depressive and psychotic symptoms may be a valuable target to reduce illness burden.

Original languageEnglish (US)
Pages (from-to)131-136
Number of pages6
JournalSchizophrenia Research
Volume171
Issue number1-3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Schizophrenia
Self Report
Depression
Cost of Illness
Psychiatry
Outpatients

Keywords

  • Awareness
  • Cognition
  • Functional capacity
  • Psychosis

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Neurocognitive insight and objective cognitive functioning in schizophrenia. / Burton, Cynthia Z.; Harvey, Philip D; Patterson, Thomas L.; Twamley, Elizabeth W.

In: Schizophrenia Research, Vol. 171, No. 1-3, 01.03.2016, p. 131-136.

Research output: Contribution to journalArticle

Burton, Cynthia Z. ; Harvey, Philip D ; Patterson, Thomas L. ; Twamley, Elizabeth W. / Neurocognitive insight and objective cognitive functioning in schizophrenia. In: Schizophrenia Research. 2016 ; Vol. 171, No. 1-3. pp. 131-136.
@article{e6c9646c3be045fb9d78ee2599dd9040,
title = "Neurocognitive insight and objective cognitive functioning in schizophrenia",
abstract = "Neurocognitive impairment is a core component of schizophrenia affecting everyday functioning; the extent to which individuals with schizophrenia show awareness of neurocognitive impairment (neurocognitive insight) is unclear. This study investigated neurocognitive insight and examined the cross-sectional relationships between neurocognitive insight and objective neurocognition and functional capacity performance in a large outpatient sample.214 participants with schizophrenia-spectrum disorders completed measures of neurocognition, functional capacity, and self-reported neurocognitive problems. Latent profile analysis classified participants with regard to neuropsychological performance and self-report of neurocognitive problems. The resulting classes were then compared on executive functioning performance, functional capacity performance, and psychiatric symptom severity.More than three quarters of the sample demonstrated objective neurocognitive impairment (global deficit score ≥ 0.50). Among the participants with neurocognitive impairment, 54{\%} were classified as having {"}impaired{"} neurocognitive insight (i.e., reporting few neurocognitive problems despite having objective neurocognitive impairment). Participants with impaired vs. intact neurocognitive insight did not differ on executive functioning measures or measures of functional capacity or negative symptom severity, but those with intact neurocognitive insight reported higher levels of positive and depressive symptoms.A substantial portion of individuals with schizophrenia and objectively measured neurocognitive dysfunction appear unaware of their deficits. Patient self-report of neurocognitive problems, therefore, is not likely to reliably assess neurocognition. Difficulty self-identifying neurocognitive impairment appears to be unrelated to executive functioning, negative symptoms, and functional capacity. For those with intact neurocognitive insight, improving depressive and psychotic symptoms may be a valuable target to reduce illness burden.",
keywords = "Awareness, Cognition, Functional capacity, Psychosis",
author = "Burton, {Cynthia Z.} and Harvey, {Philip D} and Patterson, {Thomas L.} and Twamley, {Elizabeth W.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.schres.2016.01.021",
language = "English (US)",
volume = "171",
pages = "131--136",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Neurocognitive insight and objective cognitive functioning in schizophrenia

AU - Burton, Cynthia Z.

AU - Harvey, Philip D

AU - Patterson, Thomas L.

AU - Twamley, Elizabeth W.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Neurocognitive impairment is a core component of schizophrenia affecting everyday functioning; the extent to which individuals with schizophrenia show awareness of neurocognitive impairment (neurocognitive insight) is unclear. This study investigated neurocognitive insight and examined the cross-sectional relationships between neurocognitive insight and objective neurocognition and functional capacity performance in a large outpatient sample.214 participants with schizophrenia-spectrum disorders completed measures of neurocognition, functional capacity, and self-reported neurocognitive problems. Latent profile analysis classified participants with regard to neuropsychological performance and self-report of neurocognitive problems. The resulting classes were then compared on executive functioning performance, functional capacity performance, and psychiatric symptom severity.More than three quarters of the sample demonstrated objective neurocognitive impairment (global deficit score ≥ 0.50). Among the participants with neurocognitive impairment, 54% were classified as having "impaired" neurocognitive insight (i.e., reporting few neurocognitive problems despite having objective neurocognitive impairment). Participants with impaired vs. intact neurocognitive insight did not differ on executive functioning measures or measures of functional capacity or negative symptom severity, but those with intact neurocognitive insight reported higher levels of positive and depressive symptoms.A substantial portion of individuals with schizophrenia and objectively measured neurocognitive dysfunction appear unaware of their deficits. Patient self-report of neurocognitive problems, therefore, is not likely to reliably assess neurocognition. Difficulty self-identifying neurocognitive impairment appears to be unrelated to executive functioning, negative symptoms, and functional capacity. For those with intact neurocognitive insight, improving depressive and psychotic symptoms may be a valuable target to reduce illness burden.

AB - Neurocognitive impairment is a core component of schizophrenia affecting everyday functioning; the extent to which individuals with schizophrenia show awareness of neurocognitive impairment (neurocognitive insight) is unclear. This study investigated neurocognitive insight and examined the cross-sectional relationships between neurocognitive insight and objective neurocognition and functional capacity performance in a large outpatient sample.214 participants with schizophrenia-spectrum disorders completed measures of neurocognition, functional capacity, and self-reported neurocognitive problems. Latent profile analysis classified participants with regard to neuropsychological performance and self-report of neurocognitive problems. The resulting classes were then compared on executive functioning performance, functional capacity performance, and psychiatric symptom severity.More than three quarters of the sample demonstrated objective neurocognitive impairment (global deficit score ≥ 0.50). Among the participants with neurocognitive impairment, 54% were classified as having "impaired" neurocognitive insight (i.e., reporting few neurocognitive problems despite having objective neurocognitive impairment). Participants with impaired vs. intact neurocognitive insight did not differ on executive functioning measures or measures of functional capacity or negative symptom severity, but those with intact neurocognitive insight reported higher levels of positive and depressive symptoms.A substantial portion of individuals with schizophrenia and objectively measured neurocognitive dysfunction appear unaware of their deficits. Patient self-report of neurocognitive problems, therefore, is not likely to reliably assess neurocognition. Difficulty self-identifying neurocognitive impairment appears to be unrelated to executive functioning, negative symptoms, and functional capacity. For those with intact neurocognitive insight, improving depressive and psychotic symptoms may be a valuable target to reduce illness burden.

KW - Awareness

KW - Cognition

KW - Functional capacity

KW - Psychosis

UR - http://www.scopus.com/inward/record.url?scp=84958103167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958103167&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2016.01.021

DO - 10.1016/j.schres.2016.01.021

M3 - Article

VL - 171

SP - 131

EP - 136

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1-3

ER -